Micronase is an oral antidiabetic medication belonging to the sulfonylurea class. It is used primarily to improve blood glucose control in patients with type 2 diabetes mellitus. The drug acts by stimulating pancreatic beta cells to increase insulin secretion. This increased insulin release enhances peripheral glucose uptake and inhibits hepatic gluconeogenesis. Micronase binds to the sulfonylurea receptor on beta cells, leading to closure of potassium channels. The closure of these channels causes cell depolarization and triggers calcium influx, which promotes exocytosis of stored insulin. Through these pharmacological processes the medication lowers fasting and postprandial blood glucose levels. Its therapeutic effect is achieved by decreasing insulin resistance and optimizing the body's response to endogenous insulin.

Micronase is an oral antidiabetic medication used to manage type 2 diabetes by lowering blood glucose levels. Its active ingredient glibenclamide belongs to the sulfonylurea class of drugs. The drug works by binding to potassium-atp channels on pancreatic beta cells. This binding closes the channels, leading to cell depolarization and calcium influx. The resulting calcium signal triggers the release of stored insulin into the bloodstream. Increased insulin secretion enhances glucose uptake and suppresses hepatic glucose production. By restoring physiologic insulin action Micronase reduces hyperglycemia without replacing insulin. The medication's effect is therefore dependent on the presence of functional beta cells.

Micronase can lower blood glucose levels leading to hypoglycemia. Some users experience weight gain as a side effect. Nausea and abdominal discomfort are reported occasionally. Headaches may occur especially during initial treatment. Dizziness or lightheadedness can be experienced. Skin reactions such as rash or itching have been observed.

Many patients experience mild side effects such as dizziness or headache. Some may notice gastrointestinal discomfort including nausea or abdominal cramps. Low blood sugar levels can occur leading to symptoms like weakness or sweating. Occasionally skin reactions such as rash or itching have been reported. Liver enzyme elevations are rare but have been documented in clinical studies. Fluid retention may cause swelling in the ankles or feet in certain individuals. Most side effects are reversible when the medication is discontinued or adjusted.